Cardiology

Vigilance urged for heparin-induced thrombocytopenia

(HealthDay)—Diagnosis and management of heparin-induced thrombocytopenia (HIT) are discussed in a review published in the May 31 issue of the Journal of the American College of Cardiology.

Medical research

Scientists find safer way to make common blood thinner heparin

For the first time, scientists have discovered a way to make the common blood-thinning medication heparin using human cells in the laboratory. The new method could offer a safer alternative to current heparin production methods, ...

Cardiology

Most don't need 'bridging' when they stop warfarin temporarily

(HealthDay)—Heart patients on the clot-preventing drug warfarin usually have to stop the medication before having surgery. Now, a new study shows they can safely do that without taking another anti-clotting drug—and they ...

Cardiology

Findings from the BRIGHT trial published

Data from the BRIGHT trial published today in the Journal of the American Medical Association demonstrated that bivalirudin was superior to both heparin monotherapy and heparin plus tirofiban for patients with acute myocardial ...

page 4 from 11